Goldman Sachs’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,794,373
Closed -$37.5M 6637
2022
Q3
$37.5M Buy
1,794,373
+275,897
+18% +$5.74M 0.01% 1328
2022
Q2
$31.5M Buy
1,518,476
+748,344
+97% +$13.3M 0.01% 1514
2022
Q1
$12.9M Sell
770,132
-320,011
-29% -$5.59M ﹤0.01% 2436
2021
Q4
$21.8M Buy
1,090,143
+164,135
+18% +$3.09M ﹤0.01% 2038
2021
Q3
$16.8M Buy
926,008
+252,194
+37% +$5.78M ﹤0.01% 2234
2021
Q2
$18.2M Buy
673,814
+120,978
+22% +$3.38M ﹤0.01% 2123
2021
Q1
$16.6M Buy
552,836
+168,991
+44% +$5.76M ﹤0.01% 2092
2020
Q4
$11M Sell
383,845
-625,698
-62% -$16.9M ﹤0.01% 2377
2020
Q3
$24.6M Sell
1,009,543
-201,034
-17% -$4.34M 0.01% 1567
2020
Q2
$21.7M Buy
1,210,577
+214,193
+21% +$2.82M 0.01% 1616
2020
Q1
$8.11M Buy
996,384
+521,480
+110% +$5.96M ﹤0.01% 2239
2019
Q4
$6.27M Buy
474,904
+80,552
+20% +$975K ﹤0.01% 2779
2019
Q3
$4.69M Sell
394,352
-1,251,273
-76% -$23.2M ﹤0.01% 2910
2019
Q2
$40.3M Buy
1,645,625
+989,641
+151% +$28.5M 0.01% 1299
2019
Q1
$20.9M Buy
+655,984
New +$23.3M 0.01% 1826

Other funds holding CVET

Goldman Sachs's CVET Position: Q4 2022 in Review

Goldman Sachs sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1,794,373 shares — an estimated $37.5M sold.

Goldman Sachs first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $40.3M in Q2 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Goldman Sachs reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 1,794,373 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $37.5M.
  • Goldman Sachs first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Goldman Sachs's Covetrus, Inc. Common Stock position peaked at $40.3M in Q2 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.